Zenith Healthcare share price: key details for 2026
Zenith Health Care Ltd
ZENITHHE
Ask AI
Share price snapshot (7 July 2026)
Zenith Healthcare Ltd (ticker: ZENITHHE) was at a share price of ₹3.18 as on 7 July 2026. The company is classified under the Health Care sector and the Pharmaceuticals sub-sector. It is listed on the BSE with scrip code 530665. The provided data also references a BSE-related date of 12/24/2025.
Where Zenith Healthcare fits in the market
Zenith Healthcare Limited is described as an integrated pharmaceutical company in India. Its business includes manufacturing pharmaceutical formulations and providing contract manufacturing services. The text notes that this work spans multiple therapeutic areas, indicating a diversified formulation and manufacturing footprint within pharmaceuticals.
Listing and classification details
The company is tagged as Sector: Healthcare and Industry: Pharmaceuticals & Drugs. For investors, these classifications matter because they often determine peer comparisons, screening buckets, and how the stock appears across sector trackers. The BSE identifier 530665 is the primary reference point for exchange-specific searches and corporate filings.
Registered and corporate office details
Zenith Healthcare’s registered and corporate office address is listed as:
504, Iscon Elegance, Nr. Shapath 5, S.G. Road, Ahmedabad-380015.
The contact details provided include:
- Emails: info@zenithhealthcare.com; mahendrazenith@hotmail.com (listed twice)
- Phone: (079) 66168889, (079) 66168890
- Mobile: +91 98250 97076, +91 94265 16103
These details are typically relevant for shareholder communication, vendor coordination, and official correspondence.
Manufacturing location (works)
The works location in the data is:
388/34, Changodar Ind. Estate, Sarkhej-Bawla Highway, Changodar-382 213, Dist. Ahmedabad.
The listed contact numbers for the works are:
- Phone: (02717) 250048, (02717) 250593
- Fax: (02717) 251262
This address is an operational anchor for a manufacturing-focused pharmaceutical company, particularly in the context of formulations and contract manufacturing.
Agent information listed in the data
The agent information includes a Mumbai address:
1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis, Makwana Road, Marol, Andheri (East) Mumbai 400059, Maharashtra.
The same address appears twice in the provided text. Contact points include:
- Board No: 022 62638200
- Fax: 022 62638299
Amalgamation proposal referenced (board meeting dated 19/10/2018)
The text includes a corporate action reference involving an application for amalgamation between Zenith Healthcare Limited (ZHL) as the transferee company and Zenith Medicine Pvt. Ltd. (ZMPL) as the transferor company. It also states that ZENITH HEALTH CARE LTD informed the BSE about a Board of Directors meeting scheduled on 19/10/2018. The purpose included considering and approving notice of the 4th Board Meeting (04/2018-19) and considering the proposal for amalgamation.
A separate line defines “Approval Date” as the date when shareholders and regulatory authorities approve a proposed restructuring. The text does not provide a specific approval date for the amalgamation mentioned.
How to track mergers and demergers (Pocketful instructions)
The provided material also includes steps to track mergers and demergers for Zenith Health Care Ltd on Pocketful:
- Visit the Zenith Health Care Ltd stock page on the Pocketful platform.
- Go to the Corporate Actions section.
- Select the Mergers & Demergers tab to view announced, ongoing, or completed restructuring activities.
These instructions are presented as a process guide rather than a corporate filing.
Scheme of Arrangement reference (Appointed Date: 1 April 2022)
The text further references provisions of the Companies Act, 2013 read with the Companies (Compromises, Arrangements and Amalgamations) Rules, 2016 for a Scheme of Arrangement. The scheme is described as being between Ziqitza Health Care Limited (Demerged Company) and Zenplus Private Limited (Resulting Company).
It explicitly states: “The Appointed Date for the Scheme of Arrangement is 1st day of April 2022.” No additional operational or financial details are provided in the text for this scheme.
Key facts table
What investors can take away from the disclosed information
From the information provided, the immediate market datapoint is the ₹3.18 share price as of 7 July 2026, alongside clear identifiers such as ZENITHHE and BSE 530665. The company profile points to a manufacturing-led pharmaceutical model that includes formulations and contract manufacturing across therapeutic areas.
On the corporate actions side, the text highlights that an amalgamation proposal involving Zenith Healthcare and Zenith Medicine Pvt. Ltd. was on the agenda for a board meeting on 19 October 2018, while also noting a separate Scheme of Arrangement with an Appointed Date of 1 April 2022 for Ziqitza Health Care Limited and Zenplus Private Limited. For tracking such events, the material points readers to the corporate actions workflow on Pocketful.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
